An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 012616
Company: PFIZER

Products on NDA 012616

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ALDACTAZIDE	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25MG;25MG	TABLET;ORAL	Prescription	AB	Yes	No
ALDACTAZIDE	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	50MG;50MG	TABLET;ORAL	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 012616

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/27/1961	ORIG-1	Approval	Type 4 - New Combination	STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/19/2022	SUPPL-83	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012616s083lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/012616Orig1s083ltr.pdf
02/19/2021	SUPPL-81	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012616s081lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/012616Orig1s081ltr.pdf
08/20/2020	SUPPL-80	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/012616s080lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/012616Orig1s080ltr.pdf
01/17/2019	SUPPL-78	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/012616s078lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/012616Orig1s078ltr.pdf
10/22/2014	SUPPL-76	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s076lbl.pdf
03/06/2014	SUPPL-75	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s075lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/012616Orig1s075ltr.pdf
01/17/2014	SUPPL-74	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s074lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/012616Orig1s074ltr.pdf
06/12/2013	SUPPL-73	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012616s073lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/012616Orig1s073ltr.pdf
06/14/2013	SUPPL-72	Manufacturing (CMC)		Label is not available on this site.
09/22/2011	SUPPL-69	Labeling-Package Insert	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/012616s069ltr.pdf
05/19/2011	SUPPL-68	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012616s068lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/012616s068ltr.pdf
11/26/2002	SUPPL-63	Manufacturing (CMC)-Control		Label is not available on this site.
04/21/1999	SUPPL-62	Labeling		Label is not available on this site.
01/13/1999	SUPPL-61	Labeling		Label is not available on this site.
11/13/1997	SUPPL-58	Labeling		Label is not available on this site.
01/23/1990	SUPPL-55	Manufacturing (CMC)		Label is not available on this site.
11/13/1997	SUPPL-37	Labeling		Label is not available on this site.
01/04/1978	SUPPL-16	Unspecified		Label is not available on this site.

Labels for NDA 012616

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/19/2022	SUPPL-83	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012616s083lbl.pdf
02/19/2021	SUPPL-81	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012616s081lbl.pdf
08/20/2020	SUPPL-80	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/012616s080lbl.pdf
01/17/2019	SUPPL-78	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/012616s078lbl.pdf
10/22/2014	SUPPL-76	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s076lbl.pdf
03/06/2014	SUPPL-75	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s075lbl.pdf
01/17/2014	SUPPL-74	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s074lbl.pdf
06/12/2013	SUPPL-73	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012616s073lbl.pdf
05/19/2011	SUPPL-68	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012616s068lbl.pdf

Therapeutic Equivalents for NDA 012616

ALDACTAZIDE

TABLET;ORAL; 25MG;25MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ALDACTAZIDE	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25MG;25MG	TABLET;ORAL	Prescription	Yes	AB	012616	PFIZER
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25MG;25MG	TABLET;ORAL	Prescription	No	AB	086513	MYLAN
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25MG;25MG	TABLET;ORAL	Prescription	No	AB	089534	SUN PHARM INDUSTRIES

Top